Support Laboratory Diagnosis and Monitoring to Scale up and Improve HIV/AIDS Care and Treatment Services in the Kingdom of Lesotho under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 154602CONT16

Opportunity Information: Apply for CDC RFA GH15 154602CONT16

This grant opportunity is a continuation funding announcement from the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief (PEPFAR) focused on strengthening laboratory diagnosis and ongoing monitoring to expand and improve HIV/AIDS care and treatment services in the Kingdom of Lesotho. The program sits in the health category and is structured as a cooperative agreement, which generally means CDC expects to remain actively involved with the recipient through substantial programmatic collaboration, technical input, and oversight rather than simply issuing funds with minimal engagement.

The opportunity is specifically tied to the earlier funding opportunity CDC-RFA-GH15-1546 and is not an open competition. It is intended only for organizations that were previously awarded under that original announcement, meaning new applicants are not eligible to apply through this continuation notice. In other words, the purpose here is to maintain momentum and sustain previously funded work that supports Lesotho's HIV response, rather than start new, unrelated projects or bring new implementers into the portfolio.

The core focus is laboratory support that enables high-quality HIV clinical care at scale. In practical terms, this typically includes improving access to and reliability of HIV diagnostic and monitoring tests that are central to treatment decisions and program performance, such as early diagnosis and routine patient monitoring (for example, viral load monitoring) to track treatment effectiveness. These kinds of laboratory strengthening efforts commonly involve improving laboratory systems, quality management, training and mentorship for lab personnel, strengthening specimen referral and transport networks, ensuring consistent testing capacity, and reinforcing data systems that link laboratory results to patient care so clinicians can act on results quickly and appropriately. Because the title emphasizes both diagnosis and monitoring, the funding is geared toward supporting the full continuum from identifying people living with HIV to keeping them effectively treated and virally suppressed through dependable lab services.

Administrative details in the source information indicate this continuation opportunity is labeled CDC RFA GH15 154602CONT16, reflecting it as a continuation action connected to the original GH15-1546 announcement. The CFDA number listed is 93.067, which corresponds to the CDC's global HIV/AIDS efforts under PEPFAR-related authorities. The eligible applicant category is listed broadly as "Others," but the narrative makes clear that eligibility is functionally restricted to prior awardees under the original FOA. The original closing date shown is November 30, 2015, and the creation date is September 28, 2015, which further signals that this is part of a prior funding cycle and is mainly an administrative mechanism to continue existing awards rather than solicit new proposals.

Finally, the posting shows an award ceiling of 0 and no expected awards specified, which is common in continuation notices or systems records where the funding level and number of awards are predetermined through existing agreements rather than competed through a new open call. Overall, the opportunity is best understood as CDC/PEPFAR continuing to fund established partners to keep strengthening Lesotho's HIV laboratory capacity so the national treatment program can expand services and improve clinical outcomes through accurate, timely, and high-quality testing.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Support Laboratory Diagnosis and Monitoring to Scale up and Improve HIV/AIDS Care and Treatment Services in the Kingdom of Lesotho under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-09-28.
• Applicants must submit their applications by 2015-11-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH15 154602CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: